Log in to save to my catalogue

Triazole RGD antagonist reverts TGF[beta]1-induced endothelial-to-mesenchymal transition in endothel...

Triazole RGD antagonist reverts TGF[beta]1-induced endothelial-to-mesenchymal transition in endothel...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1856101768

Triazole RGD antagonist reverts TGF[beta]1-induced endothelial-to-mesenchymal transition in endothelial precursor cells

About this item

Full title

Triazole RGD antagonist reverts TGF[beta]1-induced endothelial-to-mesenchymal transition in endothelial precursor cells

Publisher

New York: Springer

Journal title

Molecular and cellular biochemistry, 2017-01, Vol.424 (1-2), p.99

Language

English

Formats

Publication information

Publisher

New York: Springer

More information

Scope and Contents

Contents

Fibrosis is the dramatic consequence of a dysregulated reparative process in which activated fibroblasts (myofibroblasts) and Transforming Growth Factor [beta]1 (TGF[beta]1) play a central role. When exposed to TGF[beta]1, fibroblast and epithelial cells differentiate in myofibroblasts; in addition, endothelial cells may undergo endothelial-to-mese...

Alternative Titles

Full title

Triazole RGD antagonist reverts TGF[beta]1-induced endothelial-to-mesenchymal transition in endothelial precursor cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1856101768

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1856101768

Other Identifiers

ISSN

0300-8177

E-ISSN

1573-4919

DOI

10.1007/s11010-016-2847-2

How to access this item